Virios Therapeutics Inc expected to post a loss of 6 cents a share - Earnings Preview

Dogwood Therapeutics

06/08/2024 19:03

* Virios Therapeutics Inc  VIRI.OQ   VIRI.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 8 for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Virios Therapeutics Inc
is for
a loss of 6 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Virios
Therapeutics Inc is $1.00​, above​ its last closing price
of $0.19. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.04       -0.04      -0.07     Missed  -75
 Jan. 1 2024   -0.09       -0.09      -0.06     Beat    33.3
 Sep. 30 2023  -0.09       -0.09      -0.06     Beat    36.8​
 Jun. 30 2023  -0.07       -0.07      -0.08     Missed  -14.3
 ​​Mar.        -0.20       -0.20      -0.08     Beat    60
 31 2023                                                
 Dec. 31 2022  -0.15       -0.49      -0.11     Beat    29​
 Sep. 30 2022  -0.46       -0.49      -0.28     Beat    42.9
 Jun. 30 2022  -0.49       -0.50      -0.44     Beat    12.9
 This summary was machine generated August 6 at 18:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)